551. Convalescent plasma early in disease course improves survival in COVID-19

BACKGROUND: Convalescent plasma (CP) has been described as a potential therapy for coronavirus disease 2019 (COVID-19). Given paucity of data, we sought to describe characteristics of CP recipients in survivors and non-survivors. METHODS: We conducted retrospective review of electronic medical recor...

Descripción completa

Detalles Bibliográficos
Autores principales: Nauriyal, Varidhi, Shallal, Anita, Vahia, Amit T, Samuel, Linoj, Tibbetts, Robert, Lopez-Plaza, Ileana, Ramesh, Mayur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777732/
http://dx.doi.org/10.1093/ofid/ofaa439.745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777732/
http://dx.doi.org/10.1093/ofid/ofaa439.745

Ejemplares similares